Laura Mezquita

Grupo de investigación

Genómica traslacional y terapias dirigidas en tumores sólidos Junior researcher (R2B)

lmezquita@clinic.cat 0000-0003-0936-7338

Publicaciones destacadas

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer

Autores:
Auclin, E; Tonneau, M; Routy, B; Rochand, A; Benitez-Montanez, J;

(...)

Kazandjian, S; Muanza, T; Fabre, E; Arasanz, H; Mezquita, L.

Referencia: Lung Cancer 2023.
Effects of spatial variation in dose delivery: what can we learn from radon-related lung cancer studies?

Autores:
Madas, BG; Boei, J; Fenske, N; Hofmann, W; Mezquita, L;

Referencia: Radiation And Environmental Biophysics 2022.
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

Autores:
Mezquita, L; Hendriks, L; Blanc-Durand, F; Planchard, D; Besse, B;

(...)

Cassard, L; Chaput, N; Rossoni, C; Dingemans, AM; Cozic, N.

Referencia: European Journal Of Cancer 2021.
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non-Small Cell Lung Cancer

Autores:
Ortiz-Cuaran, Sandra; Mezquita, Laura; Swalduz, Aurelie; Aldea, Mihalea; Mazieres, Julien;

(...)

Perol, Maurice; Besse, Benjamin; Blay, Jean-Yves; Saintigny, Pierre; Planchard, David.

Referencia: Clinical Cancer Research 2020.
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome

Autores:
Mezquita, L; Kfoury, M; Planchard, D; Besse, B; Jové, M;

(...)

Friboulet, L; Adam, J; Green, E; Frébourg, T; Caron, O.

Referencia: Journal Of Thoracic Oncology 2020.
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting ALK and ROS1 Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung Cancer

Autores:
Mezquita, Laura; Swalduz, Aurelie; Jovelet, Cecile; Ortiz-Cuaran, Sandra; Howarth, Karen;

(...)

Massard, Christophe; Perol, Maurice; Friboulet, Luc; Besse, Benjamin; Saintigny, Pierre.

Referencia: Jco Precision Oncology 2020.
Indoor Radon in EGFR- and BRAF-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer Patients

Autores:
Mezquita, Laura; Benito, Amaro; Ruano-Ravina, Alberto; Zamora, Javier; Eugenia Olmedo, Maria;

(...)

Hernanz, Raul; Cabanero, Alberto; Auclin, Edouard; Carrato, Alfredo; Garrido, Pilar.

Referencia: Clinical Lung Cancer 2019.
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer

Autores:
Mezquita, Laura; Auclin, Edouard; Ferrara, Roberto; Charrier, Melinda; Remon, Jordi;

(...)

Lahmar, Jihene; Adam, Julien; Chaput, Nathalie; Soria, Jean Charles; Besse, Benjamin.

Referencia: Jama Oncology 2018.

Proyectos destacados

Estudio EXPOS: Exposoma y medicina de precisión en pacientes con cáncer portadores de fusiones oncogénicas: entendiendo el papel de los carcinógenos y su implicación

Investigador/a principal: Laura Mezquita Pérez

Duración: 01/01/2024
Exposome & Precision Medicine in lung Cancer: understanding the role of carcinogens in clinical care

Investigador/a principal: Laura Mezquita Pérez

Duración: 01/01/2024
Impact of circulating neutrophils and tumor-associated neutrophils (TAN) in untreated advanced NSCLC treated with inmunotherapy and /or chemotherapy

Investigador/a principal: Laura Mezquita

Financiador: SEOM (Socieadad Española de Oncología Médica)

Duración: 31/10/2021

Laura Mezquita

Grupo de investigación

Publicaciones destacadas

Proyectos destacados

Estudio EXPOS: Exposoma y medicina de precisión en pacientes con cáncer portadores de fusiones oncogénicas: entendiendo el papel de los carcinógenos y su implicación

Exposome & Precision Medicine in lung Cancer: understanding the role of carcinogens in clinical care

Impact of circulating neutrophils and tumor-associated neutrophils (TAN) in untreated advanced NSCLC treated with inmunotherapy and /or chemotherapy

Suscríbete a la Newsletter del Clínic